Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancerous breast tissue glows in new AI-enhanced MRI images

2.

Most women with early-stage breast cancer can anticipate living long lives, according to experts.

3.

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

4.

Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.

5.

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot